Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7378
    -0.0009 (-0.12%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    94,512.40
    -1,091.96 (-1.14%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,379.46
    -20.06 (-0.12%)
     
  • VOLATILITY

    13.01
    0.00 (0.00%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • CAD/EUR

    0.6844
    +0.0001 (+0.01%)
     

Canadian drugmaker Concordia says CEO to step down

(Reuters) - Canadian generic-drug maker Concordia International Corp said on Friday that Chief Executive Mark Thompson would step down after a replacement is found. Thompson's resignation comes at a time when the company is trying to raise cash to cut its $3 billion debt as it faces curbs on drug pricing from governments and companies. Reuters reported earlier this month that the company was discussing alternatives to a leveraged buyout, including selling a minority stake to a private equity firm. The talks came after negotiations about selling the company failed to produce a deal that would be acceptable to its board, sources told Reuters. A search process for a new CEO is underway, the company said. Concordia, which had a market capitalization of C$270.1 million ($202.46 million) as of Thursday close, sells drugs for conditions ranging from malaria to heart disease. Concordia's Toronto-listed shares were up 18 percent at C$6.16. The company's U.S.-listed shares were up 19 percent at $4.73. (Reporting by Anet Josline Pinto and Akankshita Mukhopadhyay in Bengaluru; Editing by Anil D'Silva and Don Sebastian)